IVF - INVO Fertility Book Valuation of Business

The daily price action for INVO Fertility Inc (IVF), a developer of assisted conception systems, is currently at 0.03. Current quotes are driven by slow product adoption by clinics and weak operational liquidity. However, exclusive INVOcell patents and strict FDA oversight create significant barriers to entry for competitors. High patient trust is based on the brand's commitment to making reproductive medicine more accessible.

IVF INVO Fertility Book Capitalization (04/29/2025 - 10/28/2026)

INVO Fertility (IVF) - metric breakdowns and financial figures

- price and consensus price forecast:
Quote Chart INVO Fertility Corp|IVF - Price Target Chart
- market capitalization data:
Market Capitalization INVO Bioscience|IVF - Total Company Value
- book capitalization data:
Share Book Value INVO Fertility|IVF - Book Capitalization|Market-to-Book Ratio invobioscience.com|IVF - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio INVO Fertility Inc|IVF - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient INVO Bioscience|IVF - Company Aggregate Debts|Debts to Book Capitalization INVO Bioscience|IVF - Company Long-Term Debt|Company Short-Term Debt INVO Fertility
Fundamental company valuation:INVO Fertility Corp - IVF

For INVO Fertility Inc, which automates embryo maturation via INVOcell systems, this metric reflects the actual net asset value minus all liabilities. By analyzing the balance sheet capital structure dynamics on GURU.Markets, an investor assesses the fundamental value of the business without market noise, making it possible to determine the extent of the premium paid for the company's technological potential at the current liquidity level.

Competitor analysis

BSX: Net Asset Value|Edwards Lifesciences - Company Book Value|RMD (resmed.com) - Book Valuation of Business|Company Book Value Insulet PODD|Net Asset Value Zimmer Biomet|CooperVision - Book Capitalization|Total Stockholders' Equity Align Corp (ALGN)|Globus Medical, Inc. - Book Capitalization|Company Net Assets TransMedics Organ Care System TMDX|Book Capitalization ATEC (Alphatec)|AORT - Book Valuation of Business|ENOV: Book Capitalization|IART (Integra LifeSciences Inc.) - Book Capitalization|Company Book Value Establishment Labs|Company Book Value betabionics.com|IRMD (IRADIMED) - Book Capitalization|Book Valuation of Business Embecta Corp EMBC|Tandem Diabetes (TNDM) - Company Net Assets|Net Asset Value Axogen Surgical AXGN|SIBN (SI-BONE, Inc.) - Book Capitalization|OFIX - Total Stockholders' Equity|Book Capitalization Bioventus|Accounting Capitalization OrthoPediatrics|TMCI - Company Net Assets|Accounting Value of Company SRTA|Company Book Value CARL (Carlsmed Inc)|Company Net Assets rxsight.com (RXST)|CLPT: Book Capitalization|Total Stockholders' Equity Stereotaxis Inc STXS|NeuroStar (STIM) - Book Capitalization|SGHT - Accounting Capitalization|Orchestra BioMed - Book Capitalization|Anika Therapeutics, Inc. (ANIK) - Book Valuation of Business|Book Capitalization NSPR|Company Net Assets Jin Medical International Ltd|Book Capitalization VANI|Book Capitalization XTNT (xtantmedical.com)|Company Book Value NeuroOne Medical Technologies NMTC|MODD - Company Book Value|Company Net Assets Myomo (MYO)|COCH - Accounting Value of Company|Book Capitalization VVOS|NVNO (enVVeno Corp) - Total Stockholders' Equity|Sintx Technologies Inc - Company Book Value|Book Value of Business tenonmed.com (TNON)|Company Net Assets LFWD|Book Capitalization autonomix.com (AMIX)|Book Capitalization BBLG|Axonics, Inc - Book Valuation of Business|Company Book Value BIOLASE, Inc.|DYNT: Net Asset Value|FNA (paragon28.com) - Company Book Value|INVO Bioscience (INVO) - Company Net Assets